The Antiepileptic Drugs market size is expected to reach $22.87 billion in 2030 at a CAGR of 5.1%, driven by treatment-resistant epilepsy management and novel antiepileptic drug approvals.
Read More
Tumor Profiling market size is expected to reach $17.96 by 2030 at 9.9%, driven by rising demand for personalized medicine.
Read More
The global Tumor Microenvironment market will grow from $2.73 billion in 2026 to $2.44 billion in 2030 at 12.1% CAGR, driven by advancements in oncology and immunotherapy technologies.
Read More
The global tumor marker testing market to reach $27.23 billion by 2030 at 7.9% cagr, driven by increasing cancer prevalence.
Read More
Tubular external fixation system market to reach $10.36 billion by 2030 at 9.3% cagr, driven by increasing incidence of orthopedic injuries.
Read More
Global Tuberculosis Therapeutics market size is expected to reach $2.7 billion by 2030 at 6.1%, impact of rising tb-hiv co-infection rates on the growth of the market
Read More
Trypsin-edta solution for cell dissociation market to reach $2.03 billion by 2030 at 8.8% cagr, driven by rising prevalence of chronic diseases.
Read More
The TrkC antibody market will reach $2.87 by 2030 at 12.1% CAGR, driven by precision medicine, neuro-oncology research, biomarker diagnostics, and antibody innovations.
Read More
Global Tropical Spastic Paraparesis market size is expected to reach $1.13 billion by 2030 at 6.4%, impact of aging population on healthcare advancements
Read More
Global Triple Negative Breast Cancer market size is expected to reach $1.48 billion by 2030 at 5.4%, improvement in healthcare facilities drives growth of the market
Read More